These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33848531)

  • 1. Is Onabotulinum Toxin-A Combined Injection in the Bowel Patch and the Bladder Remnant a Safe Alternative to Bladder Re-Augmentation?
    Sabiote L; Llorens E; Quiroz Y; Sierra L; Palou J; Bujons A
    Urology; 2021 Nov; 157():227-232. PubMed ID: 33848531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in patients at-risk for bladder augmentation: Durable impact or kicking the can?
    Bowen DK; Meyer T; Rosoklija I; Sturm R; Chu DI; Cheng EY; Yerkes EB
    Neurourol Urodyn; 2022 Aug; 41(6):1406-1413. PubMed ID: 35670258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for botulinum toxin injection and bladder augmentation after isolated bladder outlet procedure in pediatric patients with myelomeningocele.
    Smith MC; Strine AC; DeFoor WR; Minevich E; Noh P; Sheldon CA; Reddy PP; VanderBrink BA
    J Pediatr Urol; 2020 Feb; 16(1):32.e1-32.e8. PubMed ID: 31839471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease.
    Vurture G; Peyronnet B; Feigin A; Biagioni MC; Gilbert R; Rosenblum N; Frucht S; Di Rocco A; Nitti VW; Brucker BM
    Neurourol Urodyn; 2018 Nov; 37(8):2669-2677. PubMed ID: 29767449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of belladonna and opiate suppository during intravesical onabotulinum toxin A injection.
    LeClaire EL; Duong J; Wykes RM; Miller KE; Winterton TL; Bimali M
    Am J Obstet Gynecol; 2018 Nov; 219(5):488.e1-488.e7. PubMed ID: 29902447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
    Utomo E; Groen J; Blok BF
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction.
    O'Connor RC; Johnson DP; Guralnick ML
    Neurourol Urodyn; 2020 Nov; 39(8):2322-2328. PubMed ID: 32866304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative Onabotulinumtoxin-A Reduces Postoperative Narcotic and Anticholinergic Requirements After Continent Bladder Reconstruction.
    Fuchs ME; Beecroft N; McLeod DJ; Dajusta DG; Ching CB
    Urology; 2018 Aug; 118():183-188. PubMed ID: 29729360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum injection is useless on fibrotic neuropathic bladders.
    Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
    J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.
    Al Edwan GM; Mansi HH; Atta ONM; Shaath MM; Al Adwan R; Mahafza W; Afram KM; Ababneh O; Al Adwan D; Muheilan MM
    J Pediatr Surg; 2019 Mar; 54(3):595-599. PubMed ID: 29887168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study.
    Michel F; Ciceron C; Bernuz B; Boissier R; Gaillet S; Even A; Chartier-Kastler E; Denys P; Gamé X; Ruffion A; Normand LL; Perrouin-Verbe B; Saussine C; Manunta A; Forin V; De Seze M; Grise P; Tournebise H; Schurch B; Karsenty G
    Urology; 2019 Jul; 129():43-47. PubMed ID: 30926380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity.
    Peyronnet B; Roumiguié M; Castel-Lacanal E; Guillotreau J; Malavaud B; Marque P; Rischmann P; Gamé X
    Neurourol Urodyn; 2016 Feb; 35(2):267-70. PubMed ID: 25524826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
    Kajbafzadeh A; Mahboubi AH; Payabvash S
    BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder.
    Khan MK; VanderBrink BA; DeFoor WR; Minevich E; Jackson E; Noh P; Reddy PP
    J Pediatr Urol; 2016 Apr; 12(2):104.e1-6. PubMed ID: 26778185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin-A injections for idiopathic overactive bladder: a systematic review and meta-analysis.
    Cui Y; Wang L; Liu L; Zeng F; Niu J; Qi L; Chen H
    Urol Int; 2013; 91(4):429-38. PubMed ID: 23970316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-blind randomized control trial of trigonal versus nontrigonal Botulinum toxin-A injections for patients with urinary incontinence and poor bladder compliance secondary to spinal cord injury.
    Chen H; Xie K; Jiang C
    J Spinal Cord Med; 2021 Sep; 44(5):757-764. PubMed ID: 32003644
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmentation uretero-enterocystoplasty for refractory urinary tract dysfunction: a long-term retrospective study.
    Ying X; Liao L
    BMC Urol; 2021 Nov; 21(1):166. PubMed ID: 34847903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
    Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
    Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.